169 related articles for article (PubMed ID: 27689398)
1. Comparative effectiveness of image-guided radiotherapy for non-operated localized esophageal squamous cell carcinoma patients receiving concurrent chemoradiotherapy: A population-based propensity score matched analysis.
Li CC; Chen CY; Chien CR
Oncotarget; 2016 Nov; 7(44):71548-71555. PubMed ID: 27689398
[TBL] [Abstract][Full Text] [Related]
2. Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis.
Chen CY; Li CC; Chien CR
Radiother Oncol; 2016 Jul; 120(1):136-9. PubMed ID: 27207358
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy.
Kuo YH; Fang HY; Lin YS; Lein MY; Yang CY; Ho SC; Li CC; Chien CR
Thorac Cancer; 2020 Jan; 11(1):113-119. PubMed ID: 31742897
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intensity-modulated radiotherapy vs 3-dimensional conformal radiotherapy for patients with non-metastatic esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy: A population-based propensity-score-matched analysis.
Li CC; Chen CY; Chien CR
Medicine (Baltimore); 2018 Jun; 97(22):e10928. PubMed ID: 29851829
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of image-guided radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy: A population-based propensity score-matched analysis.
Li CC; Liang JA; Chen WT; Chien CR
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e197-e203. PubMed ID: 31250970
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
Chen CY; Li CC; Chien CR
World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of image-guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy.
Liang JA; Tu CY; Hsia TC; Fang HY; Li CC; Chien CR
Thorac Cancer; 2020 Sep; 11(9):2639-2649. PubMed ID: 32725779
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
9. Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis.
Zhang P; Xi M; Li QQ; Hu YH; Guo X; Zhao L; Liu H; Liu SL; Luo LL; Liu Q; Liu MZ
Oncotarget; 2016 Jul; 7(28):44686-44694. PubMed ID: 27183916
[TBL] [Abstract][Full Text] [Related]
10. Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study.
Chen WM; Yu YH; Chen M; Shia BC; Wu SY
J Thorac Oncol; 2023 Aug; 18(8):1082-1093. PubMed ID: 37085031
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose.
Li CC; Fang HY; Lin CY; Shen WC; Chien CR
Anticancer Res; 2019 Jan; 39(1):511-517. PubMed ID: 30591503
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae.
Ma L; Luo GY; Ren YF; Qiu B; Yang H; Xie CX; Liu SR; Liu SL; Chen ZL; Li Q; Fu JH; Liu MZ; Hu YH; Ye WF; Liu H
Chin J Cancer; 2017 Jan; 36(1):8. PubMed ID: 28077159
[TBL] [Abstract][Full Text] [Related]
13. Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
Lin WC; Ding YF; Hsu HL; Chang JH; Yuan KS; Wu ATH; Chow JM; Chang CL; Chen SU; Wu SY
Cancer; 2017 Oct; 123(20):3904-3915. PubMed ID: 28608916
[TBL] [Abstract][Full Text] [Related]
14. Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients.
Liu A; Wang Y; Wang X; Zhu L; Nie Y; Li M
Radiat Oncol; 2021 Oct; 16(1):195. PubMed ID: 34600574
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
Chang CL; Tsai HC; Lin WC; Chang JH; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Radiother Oncol; 2017 Oct; 125(1):73-79. PubMed ID: 28923576
[TBL] [Abstract][Full Text] [Related]
16. Consolidative chemotherapy after definitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study.
Lin CY; Lien MY; Chen CC; Fang HY; Lin YS; Chen CK; Chen JX; Lu TY; Huang TM; Hsieh TC; Sun SS; Li CC; Chien CR
BMC Gastroenterol; 2022 Aug; 22(1):381. PubMed ID: 35948871
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
Ren X; Wang L; Han C; Ren L
Radiother Oncol; 2018 Nov; 129(2):293-299. PubMed ID: 30270099
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
Song T; Du D; Zhang X; Fang M; Wu S
Dis Esophagus; 2017 Sep; 30(9):1-10. PubMed ID: 28859362
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study.
Li CC; Chen CY; Chou YH; Huang CJ; Ku HY; Chien CR
BMC Gastroenterol; 2021 Apr; 21(1):153. PubMed ID: 33827451
[TBL] [Abstract][Full Text] [Related]
20. Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study.
Li CC; Chen CY; Chou YH; Huang CJ; Ku HY; Chien CR
Thorac Cancer; 2021 Jul; 12(14):2065-2071. PubMed ID: 34028200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]